Aton

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Aton

Aton is a medication whose active ingredient is Atorvastatin, a substance classified as an HMG-CoA reductase inhibitor, commonly known as a statin. This pharmacological class is clinically recognized globally for its role in managing blood lipid levels. As a synthetic compound, Atorvastatin is most commonly manufactured as an oral tablet and is available as a prescription-only (Rx) medication.

Quick Facts

Property Description
Active ingredient Atorvastatin (INN)
Form Oral Tablet
Pharmacological class Statin
General purpose Manages blood cholesterol and fat levels
Origin Synthetic

What Type of Medicine is Aton?

Knowing that Atorvastatin is the active ingredient in Aton clarifies that its primary goal is to help manage fat levels in the blood, an effort that supports overall cardiovascular well-being. The statin class of pharmaceuticals is characterized by its mechanism of interfering with the body's internal cholesterol production. Statins are a cornerstone therapy for reducing elevated lipid levels and are among the most prescribed medications worldwide.

What is Aton Made Of and What Does It Do?

Aton consists of the active ingredient Atorvastatin combined with inactive components (excipients) necessary to form the tablet and ensure its stability and absorption. The general purpose of this medication is to significantly reduce the levels of harmful cholesterol and fats, such as LDL cholesterol and triglycerides, circulating in your bloodstream. This action assists in promoting a better lipid profile, which supports smoother blood flow and contributes to the long-term maintenance of the entire circulatory system. The use of this type of medicine is often associated with the long-term management of elevated cholesterol levels in adult patients.

What side effects are possible with Aton?

Adverse Reactions and Safety Profile

The official safety profile for Aton (Atorvastatin) organizes possible side effects by the frequency of their occurrence and the body system affected. All documented adverse reactions and safety statements originate from governmental regulatory documents.

Frequency-Classified Effects

Common adverse reactions documented in clinical trials (typically ge 1% incidence) include nasopharyngitis (common cold symptoms), headache, myalgia (muscle pain), arthralgia (joint pain), diarrhea, nausea, and flatulence.

Uncommon and Rare reactions involve other organ systems. Rare but serious reactions, such as myopathy (muscle disease) and rhabdomyolysis (severe muscle breakdown), are specifically highlighted in regulatory labeling. Other rare effects include peripheral neuropathy, pancreatitis, and severe skin reactions like Stevens-Johnson syndrome.

Serious Safety Considerations

The most clinically significant adverse effects documented are the potential for rhabdomyolysis and fatal or non-fatal hepatic failure (liver failure). Regulatory documents note that the risk of myopathy increases with higher dosages of the medication.

Routine liver enzyme tests are required by official labels prior to and during therapy, due to the documented risk of persistent hepatic transaminase elevations. Reports of cognitive impairment (such as confusion or memory loss) have occurred, which were generally non-serious and reversible upon discontinuation of the drug.

Population-Specific Restrictions

Atorvastatin is contraindicated by regulatory authorities in individuals with active liver disease or unexplained persistent liver enzyme elevations. The medication is also contraindicated for women who are pregnant or breastfeeding. Advanced age (65 years and older) is listed as a predisposing factor for muscle-related adverse reactions.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose with Aton (Atorvastatin) does not result in a specific acute symptom cluster detailed in regulatory information. Instead, exposure over prescribed limits may lead to the severe escalation of known toxicities, necessitating immediate medical intervention.

The officially documented severe outcomes are Rhabdomyolysis (severe muscle breakdown) and Hepatotoxicity (serious liver injury). Manifestations that require urgent care include unexplained muscle pain, weakness, or tenderness, and clinical signs of liver damage such as jaundice or upper abdominal pain.

Emergency Requirements Overdose Management Status
Seek immediate medical attention No specific treatment or antidote is available.
Contact a poison control center Management is defined as symptomatic and supportive.

Hospital management requires mandatory monitoring of Creatine Kinase (CK) levels and liver function tests (ALT/AST) to assess toxicity severity. The regulatory profile notes that patients with underlying renal impairment or uncontrolled hypothyroidism have predisposing factors for severe muscle toxicity in an overdose scenario. This focus on life-supportive management and organ monitoring dictates the urgent need for emergency medical care.

Therapeutic Uses of Aton

The therapeutic domain of Aton (often the placeholder for its active substance, Adenosine) is commonly used to help with acute or disruptive symptoms related to heightened physiological activity, particularly within the cardiovascular system. Its primary therapeutic application is applied in addressing certain rapid heart rhythms. These indications include supraventricular tachycardia (SVT) and use as a diagnostic agent in procedures like myocardial perfusion stress imaging.


This main use is relevant in clinical settings that involve acute or unstable symptom patterns and conditions involving episodic or fluctuating manifestations. The supportive nature of the medicine may assist with maintaining functional stability during phases when these symptoms become temporarily overwhelming. It supports the patient during difficult episodes by easing distress and contributes to easing the overall symptom load for those experiencing symptoms that create noticeable physiological strain.

Quick Fact: Relief for Heightened Physiological Activity

Regarding the drug's role in supportive care, the action is commonly used to help with returning the heart to a more stable rhythm in situations involving certain rhythm disorders. This action helps manage the distress associated with these conditions.

Regulatory References

  1. NIH MedlinePlus overview of Adenosine

Eligibility and Restrictions for Use

This section outlines the official eligibility and non-eligibility requirements for using Aton, as specified in regulatory documentation.

Eligibility Scope

Classification Affected Population Status
Contraindicated Patients with known hypersensitivity to Aton or its components. Prohibited
Active Liver Disease or unexplained persistent liver function abnormalities. Prohibited
Pregnant women and nursing mothers (lactation). Prohibited/Not Recommended
Restricted/Limited Patients with severe renal impairment (e.g., specific creatinine clearance threshold). Use Not Recommended
Females of Reproductive Potential. Requires Contraception

Official Eligibility Statements

  • Age-Related Eligibility: Aton is typically approved for use in adults and children aged 10 years or older, provided no contraindications are present. Safety and efficacy are not established in children younger than 10 years, which restricts use in this group.
  • Comorbidity Limitations: The presence of active liver disease is an absolute contraindication. For severe kidney impairment, use is often designated as not recommended due to potential toxicity and altered drug clearance.
  • Reproductive Status: Use during pregnancy is officially unsafe due to documented fetal risk, and use while breastfeeding is not recommended due to potential harm to the infant. These populations must avoid Aton.

The regulatory profile strictly defines the permitted patient population by establishing absolute prohibitions based on safety risks and mandates restrictions for vulnerable populations and those with compromised organ function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Aton indicates clinically significant interactions primarily driven by its involvement with the Cytochrome P450 (CYP) enzyme system and drug transporter proteins. These interactions necessitate specific actions to manage potential changes in drug concentration.

Documented Interaction Categories and Requirements

Interaction Mechanism/Category Practical Constraint/Requirement
Strong CYP Enzyme Inducers (e.g., rifampin, carbamazepine) Requires close monitoring or dose adjustment of Aton or the co-administered drug to prevent reduced efficacy.
Strong CYP Enzyme Inhibitors (e.g., macrolides, azole antifungals) Requires close monitoring or dose reduction of Aton or the co-administered drug due to the potential for increased drug exposure.
Drug Transporter Modulation (e.g., P-glycoprotein, OATP1B1) Requires monitoring when co-administered with other drugs that are substrates of these transporters.

Specific Substance Interactions

Co-administration with certain food products is also officially constrained. Consumption of grapefruit or grapefruit juice is documented to be avoided, as it can inhibit intestinal enzymes and potentially lead to an increase in Aton's concentration. These constraints are based solely on pharmacokinetic interactions cited in official regulatory documents.

Mechanism of Action

Aton is designed to influence core biological mechanisms by modulating specific signaling pathways. Its action is highly selective, focusing on modulating signaling patterns characteristic of specific pathways within defined molecular cascades.

Selective Receptor and Enzyme Modulation

Aton exerts its primary effect by engaging specific receptor or enzyme systems on cell surfaces, functioning to either initiate or, more commonly, block the natural signaling process. This precise targeted action is the initial molecular step that shapes the drug's activity profile and limits the signaling sequence to the relevant channels.

Pathway Control and Signal Modulation

Following binding, Aton operates within well-characterized molecular cascades to alter the entire signaling sequence. It works to modulate pathway activity in systems where specific neurochemical or humoral mediators dominate, influencing the signal amplification sequence within a molecular pathway and modulating high-frequency signal transduction.

Influence on Systemic Regulation

By adjusting these fundamental mechanisms, Aton influences feedback mechanisms that govern the physiological state. Its action involves modulating the concentration and activity of specific chemical mediators and influencing the activity pattern of targeted physiological responses, resulting in physiological adjustments that shape the final output of the targeted pathway.

Dosage and Administration Information

How to Use Aton — Official Administration Guidelines

Aton is a prescription medicine intended for oral administration and is typically used as long-term therapy, rather than for short-term or acute episodes. The established protocols for use focus on consistent daily intake and periodic dosage evaluation.


Feature Guideline
Dosing schedule The usual starting dose for adults is 10 mg or 20 mg once daily, with a maintenance range extending up to a maximum of 80 mg once daily. Dosage adjustments are typically made no sooner than four weeks after the last change.
Timing in relation to meals The tablet form can be taken at any time of the day, and administration is permitted with or without food. If an oral suspension is used, it must be administered on an empty stomach.
Age-group administration rules The maximum daily dose for pediatric patients aged 10 to 17 years is limited to 20 mg. No dosage adjustment is required for patients with renal impairment.
Missed-dose rules If a scheduled dose is missed, and more than 12 hours have elapsed from the usual time, the dose should be omitted entirely, and the patient should resume the regular schedule.

Connection to the Overall Use Protocol

The official instructions define a standardized protocol for use: oral, once-daily administration within a clearly defined dosage range. This protocol confirms the medicine's role in a long-term treatment plan, detailing how doses are initiated, maintained, and adjusted over time.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Aton


Evidence for Long-term Management of Elevated Blood Lipids and Cardiovascular Risk

The research exploring the active ingredient for long-term lipid management and cardiovascular risk is primarily based on large-scale clinical trials. These studies utilize Randomized Controlled Trials (RCTs) where many patients were observed over intermediate to long periods, often between two and five years, sometimes longer. Studies were conducted to measure changes in biomarkers, such as LDL-Cholesterol, Total Cholesterol, and Triglycerides, during the trial period.

Researchers monitored the rates of major clinical events, including non-fatal heart attack (MI), coronary death, stroke, and the necessity of revascularization procedures. Data from these studies described the measurements of clinical outcomes in patients with existing cardiovascular conditions (secondary prevention) and in those with risk factors (primary prevention). Data for certain groups remain limited, particularly for individuals considered to be at very low cardiovascular risk.


Evidence for Acute Termination of Specific Rapid Heart Rhythms

Research exploring the second therapeutic domain centers on studies evaluating the active ingredient for certain acute changes in heart function. This evidence is built from short-term Randomized Controlled Trials (RCTs) and cohort studies focused on episodes where symptoms become more noticeable in acute care settings. Studies measured the rate and time of reversion to a normal stable rhythm in patients presenting with certain types of rapid heart rhythms, known as Supraventricular Tachycardia (SVT).

Research highlights changes measured during the study period, showing patterns related to the rapid physiological response. The active ingredient was also evaluated in studies assessing its role as a diagnostic tool related to rhythm analysis. Due to the medication's very rapid, short-acting physiological effect, the research provides limited information for long-term outcomes related to recurrence of SVT episodes.


What the Evidence Base Does Not Yet Address (Uncertainty and Gaps)

Several areas of uncertainty remain across the two domains of research:

  • For the lipid-lowering domain, comparative evidence is lacking for direct, head-to-head outcomes against all available treatment options, and the evidence quality varies across studies when looking at very low-risk populations.
  • In the acute rhythm setting, the agent was studied for a highly specific purpose; studies conducted during periods of increased symptom activity do not address long-term condition management.
  • Overall, the evidence quality varies across studies when looking at highly specific subgroups in both domains, and findings describe group patterns, not personal outcomes.

Key Studies & References Adenosine - NIH Bookshelf/StatPearls

Frequently Asked Questions (FAQ)

Common questions about Aton (FAQ)


Q: How long does the effect of Aton typically last?

A: Aton is prescribed as a long-term treatment and the tablets are usually administered once daily. Official information on the active ingredient indicates that its effects on blood lipid levels are generally sustained over a 24-hour period, supporting the daily dosing schedule. This pattern helps maintain the desired physiological state associated with the medicine’s long-term purpose.


Q: What are the most serious side effects listed in the regulatory documents for Aton?

A: Regulatory documents highlight rare but serious adverse reactions that are documented in the official safety labeling. These include the potential for rhabdomyolysis, which is severe muscle breakdown, and fatal or non-fatal hepatic failure, which is severe liver failure. The information is available for review by healthcare providers when assessing the benefits and risks of therapy.


Q: Can Aton be taken with or without food?

A: According to the official product information, the tablet form of Aton is permitted to be taken at any time of day, with or without food. However, if you are prescribed the oral suspension formulation, regulatory guidelines indicate that this specific type of medicine should be administered on an empty stomach.


Q: What is the potential impact of Aton on pregnancy or breastfeeding?

A: Official information states that Aton is contraindicated for women who are pregnant or may become pregnant. This is because regulatory documents indicate a documented potential for harm to the fetus. The medicine is also contraindicated for women who are breastfeeding due to the potential for harm to the infant.


Q: What happens when Aton is stopped?

A: Regulatory information describes Aton as a long-term therapy intended to help manage chronic conditions. Stopping therapy typically results in the gradual return of cholesterol and fat levels to the individual's original, baseline values. The medicine is prescribed as a long-term therapy, and any adjustments to the regimen are generally made under medical supervision.


Q: Can Aton interact with blood pressure medication?

A: Official documents list specific interaction mechanisms primarily involving the body’s enzyme systems and drug transporters. While the label does not list every single medicine, it confirms that co-administration with other prescription medications must be monitored. This management is necessary to control the potential for changes in the concentration of Aton or the co-administered drug.


Q: Is Aton a type of antibiotic or something else?

A: Aton is not an antibiotic. Its active ingredient, Atorvastatin, is classified in regulatory documents as an HMG-CoA reductase inhibitor. This pharmacological class of medicines is commonly referred to as a statin, which is primarily used to manage blood cholesterol and fat levels.


Q: Can Aton be used by older adults?

A: Aton is approved for adult use. Regulatory documents note that advanced age (defined as 65 years and older) is listed as a predisposing factor for certain muscle-related adverse reactions, such as myalgia. The official guidelines do not specify restrictions on use in this population, but the listing of advanced age as a predisposing factor is a documented fact.


Q: Do any known interactions exist between Aton and common supplements like vitamins?

A: The official labeling does not specify common vitamins or general supplements. However, it provides details on known drug interactions governed by the Cytochrome P450 (CYP) enzyme system and drug transporters. Official guidelines note the importance of informing healthcare providers about all concomitant medications and supplements being used.


Q: Are there any specific foods or drinks to avoid while taking Aton?

A: Consumption of grapefruit and grapefruit juice is documented in regulatory labeling as constrained. This constraint is based on the fact that grapefruit can inhibit intestinal enzymes, which may lead to an increase in the concentration of Aton in the body.


Q: Does Aton require any special monitoring or lab tests?

A: Yes, official labeling requires routine liver enzyme tests both prior to starting and periodically during therapy. This monitoring is necessary due to the documented risk of persistent hepatic transaminase elevations associated with the medicine.


Q: Can Aton affect birth control pills?

A: Regulatory labeling states that the levels of certain components in oral contraceptives, specifically norethindrone and ethinyl estradiol, may be increased when co-administered with this medicine. Information on this potential interaction is available for review by healthcare providers.


Q: Is Aton available in a generic version?

A: Yes, Aton’s active ingredient, Atorvastatin, is widely available as a generic version. This is in addition to the original brand-name product. The use of generic medications is a common practice for many pharmaceutical classes.


Q: Are there any restrictions on driving or operating machinery while taking Aton?

A: Regulatory documents note that reports of cognitive impairment have occurred, which were generally non-serious and reversible upon discontinuation. Regulatory information notes that patients should be aware of how they react to the medication before driving or operating machinery.


Q: Does Aton have any reported effects on mood or mental clarity?

A: Regulatory documents mention reports of cognitive impairment, such as memory loss or confusion. These effects are generally described as reversible upon discontinuation of the medicine. The official labeling for this class of medicine also lists depression as a possible reported adverse event.


Q: Is Aton known to interact with alcohol?

A: Official warnings state that the medicine should be used with caution in patients who consume substantial quantities of alcohol. This is because heavy alcohol consumption may increase the risk of liver-related adverse effects documented in the product label.


Q: What age group is Aton approved for?

A: Aton is typically approved for use in adults and pediatric patients aged 10 years or older for specific approved indications. The official prescribing information provides specific dosage guidance for both adult and pediatric patients in this approved age range.


Q: Does Aton have any potential for causing allergic reactions?

A: Yes, official documents list known hypersensitivity to Aton or any of its components as an absolute contraindication for use. This means that individuals who have had an allergic reaction to the medicine should not take it.


Q: Are there different strengths or formulations of Aton?

A: Yes, the official labeling describes Aton as being available in different strengths (e.g., 10 mg, 20 mg, 40 mg, 80 mg) to support various treatment needs. It is also available in different formulations, specifically the oral tablet and an oral suspension.

How should Aton be stored and disposed of?

Official Storage Conditions

Atorvastatin tablets (Aton) must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F), with brief excursions permissible between 15 C and 30 C. The container must be kept tightly closed to protect the medicine from moisture and excessive heat.

Handling and Safety

It is required to keep the medication in its original container and keep it from freezing. A critical safety requirement is to store Aton securely, out of the sight and reach of children.

Disposal Requirements

Unused or expired Atorvastatin must be discarded according to local regulations. The preferred method for disposal is utilizing a government-approved drug take-back program or collecting waste points. The medicine should not be flushed down a toilet or washed down a sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Aton found in:

A-Z Index: